Literature DB >> 10636844

The second messenger binding site of inositol 1,4,5-trisphosphate 3-kinase is centered in the catalytic domain and related to the inositol trisphosphate receptor site.

U Bertsch1, C Deschermeier, W Fanick, I Girkontaite, K Hillemeier, H Johnen, W Weglöhner, F Emmrich, G W Mayr.   

Abstract

A segment of inositol 1,4,5-trisphosphate 3-kinase responsible for inositol 1,4,5-trisphosphate (InsP(3)) binding was characterized and confirmed by three different approaches employing the fully active expressed catalytic domain of the enzyme. Part of this moiety was protected from limited tryptic proteolysis by InsP(3). Sequencing of two fragments of 16 and 21 kDa, generated in the absence or presence of InsP(3), respectively, identified segment Glu-271 to Arg-305 as being protected. 15 monoclonal antibodies, all binding to epitopes within this region, inhibited enzyme activity and interfered with inositol phosphate binding. Detailed enzyme kinetic parameters of 32 site-directed mutants revealed residues Arg-276 and Lys-303 in this segment and Arg-322, located nearby, as directly involved in and five other closely neighbored residues, all located within a segment of 73 amino acids, as also influencing InsP(3) binding. Part of this region is similar in sequence to an InsP(3) binding segment in InsP(3) receptors. Combined with the finding that mutants influencing only ATP binding all lie outside this region, these data indicate that an InsP(3) binding core domain is inserted between two segments acting together in ATP binding and phosphate transfer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10636844     DOI: 10.1074/jbc.275.3.1557

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Mammalian inositol polyphosphate multikinase synthesizes inositol 1,4,5-trisphosphate and an inositol pyrophosphate.

Authors:  A Saiardi; E Nagata; H R Luo; A Sawa; X Luo; A M Snowman; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  The inositol pyrophosphate synthesis pathway in Trypanosoma brucei is linked to polyphosphate synthesis in acidocalcisomes.

Authors:  Ciro D Cordeiro; Adolfo Saiardi; Roberto Docampo
Journal:  Mol Microbiol       Date:  2017-08-22       Impact factor: 3.501

3.  Cloning and expression of a cDNA encoding human inositol 1,4,5-trisphosphate 3-kinase C.

Authors:  V Dewaste; V Pouillon; C Moreau; S Shears; K Takazawa; C Erneux
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

4.  Phospholipase C of Cryptococcus neoformans regulates homeostasis and virulence by providing inositol trisphosphate as a substrate for Arg1 kinase.

Authors:  Sophie Lev; Desmarini Desmarini; Cecilia Li; Methee Chayakulkeeree; Ana Traven; Tania C Sorrell; Julianne T Djordjevic
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

5.  Identification of the actin-binding domain of Ins(1,4,5)P3 3-kinase isoform B (IP3K-B).

Authors:  Maria A Brehm; Isabell Schreiber; Uwe Bertsch; Albrecht Wegner; Georg W Mayr
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

6.  IP6K gene identification in plant genomes by tag searching.

Authors:  Fabio Fassetti; Ofelia Leone; Luigi Palopoli; Simona E Rombo; Adolfo Saiardi
Journal:  BMC Proc       Date:  2011-05-28

7.  Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl.

Authors:  G Monaco; E Decrock; H Akl; R Ponsaerts; T Vervliet; T Luyten; M De Maeyer; L Missiaen; C W Distelhorst; H De Smedt; J B Parys; L Leybaert; G Bultynck
Journal:  Cell Death Differ       Date:  2011-08-05       Impact factor: 15.828

Review 8.  Fungal Kinases With a Sweet Tooth: Pleiotropic Roles of Their Phosphorylated Inositol Sugar Products in the Pathogenicity of Cryptococcus neoformans Present Novel Drug Targeting Opportunities.

Authors:  Sophie Lev; Cecilia Li; Desmarini Desmarini; Tania C Sorrell; Adolfo Saiardi; Julianne T Djordjevic
Journal:  Front Cell Infect Microbiol       Date:  2019-07-15       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.